Chini R - Search Results

1

Dupilumab Improves Facial Pain and Reduces Rescue Treatments in Patients with CRSwNP and Recalcitrant Frontal Sinusitis.

De Corso E, Settimi S, Penazzi D, D'Agostino G, Corbò M, Rigante M, Montuori C, Rizzuti A, Pacilli MC, Di Cesare T, Lo Verde S, Rizzi A, Chini R, Galli J. De Corso E, et al. Among authors: chini r. J Pers Med. 2024 Jul 9;14(7):735. doi: 10.3390/jpm14070735. J Pers Med. 2024. PMID: 39063989 Free PMC article.

2

Eosinophilic oesophagitis (in nickel-allergic patient) regressed after nickel oral desensitization: A case report.

Nucera E, Chini R, Rizzi A, Schiavino D, Buonomo A, Aruanno A, Ricci R, Mangiola F, Campanale MC, Gasbarrini A, Petruzziello L. Nucera E, et al. Among authors: chini r. Int J Immunopathol Pharmacol. 2019 Jan-Dec;33:2058738419827771. doi: 10.1177/2058738419827771. Int J Immunopathol Pharmacol. 2019. PMID: 30834798 Free PMC article.

3

Datterino Trial: A Double Blind, Randomized, Controlled, Crossover, Clinical Trial on the Use of Hydroponic Cultivated Tomato Sauce in Systemic Nickel Allergy Syndrome.

Rizzi A, Chini R, Porcari S, Settanni CR, Persichetti E, Mora V, Fanali C, Leonetti A, Parrinello G, Lohmeyer FM, Inchingolo R, Mele MC, Gasbarrini A, Nucera E. Rizzi A, et al. Among authors: chini r. J Clin Med. 2022 Sep 16;11(18):5459. doi: 10.3390/jcm11185459. J Clin Med. 2022. PMID: 36143107 Free PMC article.

4

Emerging Role of Alarmins in Food Allergy: An Update on Pathophysiological Insights, Potential Use as Disease Biomarkers, and Therapeutic Implications.

Rizzi A, Lo Presti E, Chini R, Gammeri L, Inchingolo R, Lohmeyer FM, Nucera E, Gangemi S. Rizzi A, et al. Among authors: chini r. J Clin Med. 2023 Apr 4;12(7):2699. doi: 10.3390/jcm12072699. J Clin Med. 2023. PMID: 37048784 Free PMC article. Review.

5

The Emerging Role of Innate Lymphoid Cells (ILCs) and Alarmins in Celiac Disease: An Update on Pathophysiological Insights, Potential Use as Disease Biomarkers, and Therapeutic Implications.

Rizzi A, Di Gioacchino M, Gammeri L, Inchingolo R, Chini R, Santilli F, Nucera E, Gangemi S. Rizzi A, et al. Among authors: chini r. Cells. 2023 Jul 21;12(14):1910. doi: 10.3390/cells12141910. Cells. 2023. PMID: 37508573 Free PMC article. Review.

6

Sinonasal Outcomes Obtained after 2 Years of Treatment with Benralizumab in Patients with Severe Eosinophilic Asthma and CRSwNP: A "Real-Life" Observational Study.

De Corso E, Mele DA, Rizzi A, Spanu C, Corbò M, Pisciottano S, Mastrapasqua RF, Baroni S, Porru DP, De Maio G, Rizzuti A, Di Bella GA, Ortolan A, Bonini M, Cefaloni F, Boccabella C, Lombardi F, Chini R, Caruso C, Panfili M, Galli J. De Corso E, et al. Among authors: chini r. J Pers Med. 2024 Sep 23;14(9):1014. doi: 10.3390/jpm14091014. J Pers Med. 2024. PMID: 39338268 Free PMC article.

7

HLA-DRB1 haplotype associates with selection of lipid transfer protein variants as targets of food allergy.

Nucera E, Valentini M, Mezzacappa S, Migliara G, Chini R, Rizzi A, Aruanno A, Ria F. Nucera E, et al. Among authors: chini r. J Biol Regul Homeost Agents. 2019 Jul-Aug;33(4):1293-1298. J Biol Regul Homeost Agents. 2019. PMID: 32107908 No abstract available.

8

Nickel allergy in lipid transfer protein sensitized patients: Prevalence and clinical features.

Rizzi A, Chini R, Inchingolo R, Carusi V, Pandolfi F, Gasbarrini A, Nucera E. Rizzi A, et al. Among authors: chini r. Int J Immunopathol Pharmacol. 2020 Jan-Dec;34:2058738420974895. doi: 10.1177/2058738420974895. Int J Immunopathol Pharmacol. 2020. PMID: 33242297 Free PMC article.

9

Diet Intervention Study through Telemedicine Assistance for Systemic Nickel Allergy Syndrome Patients during the COVID-19 Pandemic.

Nucera E, Rizzi A, Chini R, Giangrossi S, Lohmeyer FM, Parrinello G, Musca T, Miggiano GAD, Gasbarrini A, Inchingolo R. Nucera E, et al. Among authors: chini r. Nutrients. 2021 Aug 23;13(8):2897. doi: 10.3390/nu13082897. Nutrients. 2021. PMID: 34445054 Free PMC article.

10

Efficacy of omalizumab in reducing latex allergy.

Aruanno A, Chini R, Nucera E. Aruanno A, et al. Among authors: chini r. Postepy Dermatol Alergol. 2021 Oct;38(5):921-923. doi: 10.5114/ada.2021.110072. Epub 2021 Nov 5. Postepy Dermatol Alergol. 2021. PMID: 34849147 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters